[HTML][HTML] A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis

T Li, B Nickel, P Ngo, K McFadden, M Brennan… - The Breast, 2023 - Elsevier
Background Breast cancer care has been affected by the COVID-19 pandemic. This
systematic review aims to describe the observed pandemic-related changes in clinical and …

Assessment of time-to-treatment initiation and survival in a cohort of patients with common cancers

EB Cone, M Marchese, M Paciotti… - JAMA network …, 2020 - jamanetwork.com
Importance Resource limitations because of pandemic or other stresses on infrastructure
necessitate the triage of time-sensitive care, including cancer treatments. Optimal time to …

Onco-Breastomics: An Eco-Evo-Devo Holistic Approach

AN Neagu, D Whitham, P Bruno, A Arshad… - International Journal of …, 2024 - mdpi.com
Known as a diverse collection of neoplastic diseases, breast cancer (BC) can be
hyperbolically characterized as a dynamic pseudo-organ, a living organism able to build a …

Lockdown of breast cancer screening for COVID-19: possible scenario

G Vanni, M Pellicciaro, M Materazzo, V Bruno, C Oldani… - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: Coronavirus disease is spreading worldwide. Due to fast transmission and
high fatality rate drastic emergency restrictions were issued. During the lockdown, only …

How did women with breast cancer experience the first wave of the COVID-19 pandemic? A qualitative study

J Savard, A Jobin-Théberge, V Massicotte… - Supportive care in …, 2021 - Springer
Objective The ongoing COVID-19 global pandemic is a stressful experience that is
particularly likely to negatively affect cancer patients. The goal of this qualitative study was to …

Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer

M Chavez-MacGregor, X Lei… - JNCI: Journal of the …, 2023 - academic.oup.com
Background Medicaid expansion under the Affordable Care Act extends eligibility for
participating states and has been associated with improved outcomes by facilitating access …

Delay in breast cancer diagnosis and its clinical consequences during the coronavirus disease pandemic

B Koca, M Yildirim - Journal of surgical oncology, 2021 - Wiley Online Library
Objective At the end of 1 year of the coronavirus disease (COVID‐19) pandemic, we aimed
to reveal the changes in breast cancer cases in the context of cause and effect based on the …

Breast cancer diagnosis in coronavirus-era: alert from italy

G Vanni, M Pellicciaro, M Materazzo, L Palombi… - Frontiers in …, 2020 - frontiersin.org
SARS-COV-2 is currently spreading all over the world, exhibiting a trend that has been
defined by the WHO as a pandemic. Italy was the first European country to be involved in …

Tor Vergata University-Hospital in the beginning of COVID-19-Era: Experience and recommendation for breast cancer patients

OC Buonomo, M Materazzo, M Pellicciaro, J Caspi… - in vivo, 2020 - iv.iiarjournals.org
COVID-19 has been officially declared as a pandemic by the WHO. Italy was the first
European country to be strongly affected by this outbreak. All elective and health promotion …

Pattern of breast cancer presentation during the COVID-19 pandemic: results from a cohort study in the UK

K Borsky, K Shah, G Cunnick, F Tsang-Wright - Future Oncology, 2022 - Taylor & Francis
Background: This study aimed to explore the hypothesis that the stage of breast cancer at
initial diagnosis in 2020 is more advanced compared with 2019. Methods: Tumor, node …